6533b823fe1ef96bd127ebc9

RESEARCH PRODUCT

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial

Rosa AyalaInmaculada RapadoEsther OnechaDavid Martínez-cuadrónGonzalo Carreño-tarragonaJuan Miguel Bergua BurguesSusana Vives PoloJesus Lorenzo AlgarraMar TormoPilar MartinezJosefina SerranoPilar HerreraFernando RamosOlga SalameroEsperanza LavillaCristina GilJose Luis López LorenzoMaría Belén VidrialesJorge LabradorJosé Francisco FalantesMaría José SayasBruno PaivaEva BarragánFelipe ProsperMiguel A. SanzJoaquín Martínez-lópezPau MontesinosUniversitat Autònoma De Barcelona

subject

Neuroblastoma RAS viral oncogene homologOncologyCancer Researchgenetic riskMyeloid neoplasialeukemic cells0302 clinical medicinecytarabineclinical trials and observations:Other subheadings::/diagnosis [Other subheadings]MedicineComplete remissionazacytidineolder adultsRC254-282variantsLeukemiaAzacytidineHazard ratioleukemiaVariantsCytarabineacute:Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia Myeloid::Leukemia Myeloid Acute [DISEASES]Neoplasms. Tumors. Oncology. Including cancer and carcinogensMyeloid leukemiaFludarabineLeukemiaOncology030220 oncology & carcinogenesisNGSOlder adultsLeucèmia mieloide aguda - Tractamentmyeloid neoplasiaMyelocyticmedicine.drugmedicine.medical_specialtymyelocyticcomplete remission:Otros calificadores::/diagnóstico [Otros calificadores]Subgroup analysisLeukemic cellsAcutePrognostic factorsArticle:neoplasias::neoplasias por tipo histológico::leucemia::leucemia mieloide::leucemia mieloide aguda [ENFERMEDADES]03 medical and health sciencesInternal medicineGenetic riskbusiness.industryprognostic factors:diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]Odds ratio:Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]medicine.diseaseAvaluació de resultats (Assistència sanitària)CytarabinebusinessClinical trials and observations030215 immunology

description

This article belongs to the Collection The Biomarkers for the Diagnosis and Prognosis in Cancer.

10.3390/cancers13102458https://ddd.uab.cat/record/255656